Alzheimer's disease and glaucoma: Is there a causal relationship?

British Journal of Ophthalmology

Volumn 93, Issue 12, 2009, Pages 1557-1559

  Wostyn, P ^a   Audenaert, K ^b   De Deyn, P P ^c,d  

^a PC Sint Amandus ^*  (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c MIDDELHEIM HOSPITAL   (Belgium)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; APOLIPOPROTEIN E4; CASPASE;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID PRESSURE; CONCEPTUAL FRAMEWORK; DISEASE ASSOCIATION; ENZYME ACTIVATION; GENETIC ASSOCIATION; GLAUCOMA; HIGH RISK PATIENT; HUMAN; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; NEUROPATHOLOGY; NONHUMAN; OPEN ANGLE GLAUCOMA; OPTIC NERVE LESION; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; REVIEW; VITREOUS BODY;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID PRESSURE; GLAUCOMA; HUMANS; RISK FACTORS;

EID: 72449167431     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.148064     Document Type: Review

References (30)

1. Bullock R, Hammond G. Realistic expectations: the management of severe Alzheimer disease. Alzheimer Dis Assoc Disord 2003;17(Suppl 3):S80-5. (Pubitemid 37205720)
2. Rocchi A, Pellegrini S, Siciliano G, et al. Causative and susceptibility genes for Alzheimer's disease: a review. Brain Res Bull 2003;61:1-24. (Pubitemid 36682979)
3. Sloane PD, Zimmerman S, Suchindran C, et al. The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances. Annu Rev Public Health 2002;23:213-231
4. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001;81:741-766 (Pubitemid 32267077)
5. Sun X, He G, Qing H, et al. Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci U S A 2006;103:18727-18732 (Pubitemid 44913478)
6. de Quervain DJ, Poirier R, Wollmer MA, et al. Glucocorticoid-related genetic susceptibility for Alzheimer's disease. Hum Mol Genet 2004;13:47-52. (Pubitemid 38072134)
7. Horsburgh K, McCarron MO, White F, et al. The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models. Neurobiol Aging 2000;21:245-255 (Pubitemid 30387083)
8. Tamura H, Kawakami H, Kanamoto T, et al. High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease. J Neurol Sci 2006;246:79-83. (Pubitemid 43815345)
9. LaFerla FM. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci 2002;3:862-872 (Pubitemid 135706704)
10. Wostyn P, Audenaert K, De Deyn PP. Alzheimer's disease-related changes in diseases characterized by elevation of intracranial or intraocular pressure. Clin Neurol Neurosurg 2008;110:101-9.
11. McKinnon SJ. Glaucoma: ocular Alzheimer's disease? Front Biosci 2003;8:s1140-56.
12. Mabuchi F, Tang S, Ando D, et al. The apolipoprotein E gene polymorphism is associated with open angle glaucoma in the Japanese population. Mol Vis 2005;11:609-612 (Pubitemid 41410214)
13. Lake S, Liverani E, Desai M, et al. Normal tension glaucoma is not associated with the common apolipoprotein E gene polymorphisms. Br J Ophthalmol 2004;88:491-493 (Pubitemid 38437866)
14. Guo L, Salt TE, Luong V, et al. Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci U S A 2007;104:13444-13449
15. Wostyn P. Can chronic increased intracranial pressure or exposure to repetitive intermittent intracranial pressure elevations raise your risk for Alzheimer's disease? Med Hypotheses 2004;62:925-930
16. Engelborghs S, De Vreese K, Van de Casteele T, et al. Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia. Neurobiol Aging 2007;29:1143-1159 (Pubitemid 351822410)
17. Yoneda S, Hara H, Hirata A, et al. Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases. Jpn J Ophthalmol 2005;49:106-108 (Pubitemid 40603154)
18. Gupta N, Fong J, Ang LC, et al. Retinal tau pathology in human glaucomas. Can J Ophthalmol 2008;43:53-60. (Pubitemid 351269569)
19. McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, et al. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci 2002;43:1077-1087
20. Hinton DR, Sadun AA, Blanks JC, et al. Optic-nerve degeneration in Alzheimer's disease. N Engl J Med 1986;315:485-487
21. Blanks JC, Hinton DR, Sadun AA, et al. Retinal ganglion cell degeneration in Alzheimer's disease. Brain Res 1989;501:364-372 (Pubitemid 19259642)
22. Bayer AU, Ferrari F, Erb C. High occurrence rate of glaucoma among patients with Alzheimer's disease. Eur Neurol 2002;47:165-168 (Pubitemid 34253039)
23. Kountouras J, Zavos C, Gavalas E, et al. Normal-tension glaucoma and Alzheimer's disease: Helicobacter pylori as a possible common underlying risk factor. Med Hypotheses 2007;68:228-229
24. Kessing LV, Lopez AG, Andersen PK, et al. No increased risk of developing Alzheimer disease in patients with glaucoma. J Glaucoma 2007;16:47-51. (Pubitemid 46114773)
25. Berdahl JP, Allingham RR, Johnson DH. Cerebrospinal fluid pressure is decreased in primary open-angle glaucoma. Ophthalmology 2008;115:763-768
26. Pasquale LR. Low intracranial pressure: a tipping point in our understanding of primary open-angle glaucoma? Ophthalmology 2008;115:761-762
27. Jonas JB, Berenshtein E, Holbach L. Anatomic relationship between lamina cribrosa, intraocular space, and cerebrospinal fluid space. Invest Ophthalmol Vis Sci 2003;44:5189-5195 (Pubitemid 37475388)
28. Silverberg G, Mayo M, Saul T, et al. Elevated cerebrospinal fluid pressure in patients with Alzheimer's disease. Cerebrospinal Fluid Res 2006;3:7. (Pubitemid 44219137)
29. Silverberg GD, Huhn S, Jaffe RA, et al. Downregulation of cerebrospinal fluid production in patients with chronic hydrocephalus. J Neurosurg 2002;97:1271-1275 (Pubitemid 35424279)
30. Silverberg GD, Mayo M, Saul T, et al. Continuous CSF drainage in AD. Results of a double-blind, randomized, placebo-controlled study. Neurology 2008;71:202-209